Servier and X-Chem Announce Drug Discovery Collaboration in Neurological Diseases

Jan 11, 2021

Servier, a global pharmaceutical Group and X-Chem, Inc., a privately held drug discovery company announced today a partnership to identify and develop novel small molecules for the treatment of neurological disorders.

Posted by Servier BioInnovation

Download Attachment

See all Member News